6272 WEST 91ST AVENUE, WESTMINSTER, CO
Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery TM (PEDD TM) Portfolio for Liver Embolization
Reports Second Quarter 2026 Results
Shareholder votes
Reports First Quarter 2026 Results Commercial and Clinical Progress for Facilitating Long-Term Growth
Chief of Clinical Operations Jodi Devlin Announces Retirement
Appoints Richard Marshall, M.D., as Chief Medical Officer
Financial Results, Press Release
Material Contracts, Other Events
Q2
Q1
FY 2025
Q3
Amended Annual Report
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
S-4/A
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Amended Tender Offer Statement by Issuer
Submission Upload
Correspondence